The Annexure

News to 2 November 2026 ·

Desk›Healthcare› Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Ltd

BSE 524661 · NSE WELCURE · ISIN INE331C01025 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹0.20

-4.76%

BSE close, 28 August 2026

Market cap

₹24.72 cr

123.6 cr shares · Micro cap

Free float

₹24.72 cr

as published

P/E · P/B

-1.4× · 0.24×

EPS ₹-0.14 · BV ₹0.83

FY25-26 rev / PAT

365.54 / -5.49

₹ cr, as filed

Filings, window

1

0 selected · 0%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹0.20 52-WK HIGH ₹0.96 ₹0.20 0% of range
Against 52-week high-79.2%
Against 52-week low+0.0%
Day change-4.76%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-0.14
Price / earnings-1.43×
Price / book0.24×
Book value — derived, price ÷ P/B₹0.83
Return on equity-16.68%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
-16.78%
ROE as published
-16.68%

Reported results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q — -49.86 -0.40 — —
Dec-25 · Q — 1.07 0.13 — —
FY25-26 365.54 -5.49 -0.04 -1.50% -1.50%

Quarter on quarter

Net profit, quarter on quarter
-4,759.8%

Disclosure profile 1 filings in the window

0 median 15.0 sector max 71 1 1th percentile of 303 Healthcare filers
Shaded is the middle half of the sector, 11 to 22 filings. Measured against the 303 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Procedural
Outcome1
Procedural sub-total1
Total1

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 109 trading days

1 filings · 0 selected · busiest 2026-11-02

Filings

1 in the window · 3 earlier on record

  1. 2 November 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On October 31, 2026

    Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements

    Others / Outcome without intimation View filing →

RSS feed for Welcure Drugs & Pharmaceuticals Ltd · the 50 most recent filings